Search

everythinglearnresearchcommunity

for

Search:↓

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

GLP-1 agonists may increase the risk of hair loss.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

GLP-1RA therapy may increase the risk of hair loss.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Targeting the PGD2-DP2 pathway may help treat hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Blocking a protein called prostaglandin D2 might help treat hair loss.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Analog 23 is a promising compound for prostate cancer treatment.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Paroxetine relieves pain by increasing allopregnanolone levels.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

New progesterone-based compounds can block male hormones.